Program leadership for biotech and pharma teams navigating critical development milestones.
NanoCoeur provides experienced leadership for complex development programs, helping teams align priorities, coordinate cross-functional execution, and prepare for milestone-critical decisions with greater clarity.
Independent, senior-level support
Built for companies that need experienced program leadership before building excess infrastructure in-house.
IND-enabling work, governance refinement, execution risk visibility, and transition planning across development stages.
Built for organizations that need clarity, structure, and leadership at consequential stages.
This model is designed for development-stage companies and decision-makers who need experienced program support without the delay or overhead of building a larger internal function too early.
Emerging biotech companies
For lean organizations preparing for key filings, study transitions, operational scale-up, or stronger milestone sequencing.
Clinical and development teams
For cross-functional groups that need more consistent alignment across clinical, regulatory, CMC, quality, finance, and operations.
Executives, boards, and hiring leaders
For decision-makers seeking trusted leadership capacity during program transitions, operational resets, or milestone-critical planning.
Focused capabilities framed around execution, governance, and development-stage readiness.
The emphasis is not on a broad consulting menu. It is on the leadership functions that matter most when programs become more complex, interdependent, and time-sensitive.
Program Leadership & Governance
Establish priorities, accountability, milestone structure, and the decision cadence required to keep complex efforts moving with discipline.
Development Strategy & Operational Readiness
Support planning across pre-IND, IND-enabling work, early clinical execution, and the preparation required for Phase 2 progression.
Cross-Functional Execution
Coordinate workstreams across regulatory, clinical, CMC, quality, finance, and operations so interdependencies are visible and manageable.
Risk, Readiness & Decision Support
Improve visibility into dependencies, execution risk, and milestone-critical decisions at stages where ambiguity carries real cost.
CMC, Supply Chain & Commercial Readiness
Support CMA�trategy, supply chain planning, and commercial launch preparation — along with the operational and financial modeling required for milestone decisions and investor engagement.
AI Program Leadership
Lead AI tool evaluations, governance guardrail design, workflow automation, and executive AI strategy — translating implementation potential into operational reality for life sciences teams.
A practical model for leadership support during critical stages.
NanoCoeur works with biotech and pharma teams that need experienced program leadership without adding unnecessary process or organizational overhead.
Assess
Review current program state, constraints, interdependencies, and the decisions most likely to shape near-term progress.
Align
Clarify priorities, ownership, governance, and the execution path required for stronger readiness and fewer cross-functional blind spots.
Lead
Provide hands-on program leadership and execution support where discipline, visibility, and momentum are needed most.
Ihab Rashad, MBA, PMP
Life Sciences Program & Operations Leader · Greater Boston, MA
Biotech/pharma program and operations leader with 15+ years advancing drug, medical device, and diagnostic programs from concept through commercialization. Known for building high-performing PMOs, securing FDA approvals, optimizing global portfolios, and supporting $50M+ in funding rounds — with active AI implementation work spanning governance, workflow automation, and executive decision enablement.
Editorial direction that reinforces scientific and operational credibility.
The content strategy should remain tightly focused on program leadership, milestone readiness, governance, and cross-functional execution in biotech and pharma.
From IND to NDA: how strong program leadership protects timeline integrity
Explore how governance, sequencing, and decision visibility reduce execution drag across development stages.
Read directionWhat lean biotech teams need before building a full program management function
A focused view of structure, ownership, and operating cadence for companies approaching major inflection points.
Read directionCoordinating clinical, regulatory, and CMC priorities with greater clarity
Practical considerations for aligning multiple workstreams when the cost of delay or confusion is high.
Read directionNeed experienced program leadership at a critical stage?
NanoCoeur supports biotech and pharma teams navigating complex milestones from pre-IND through Phase 2. For consulting inquiries, introductions, or referred opportunities, get in touch to discuss fit.
Start a conversation
To empower Life Sciences organizations by bridging the gap between innovative vision and operational excellence through agile, strategic leadership across the product development lifecycle.
NanoCoeur Consulting helps life science companies bridge the gap between R&D and commercialization. We provide operational, strategic, and program leadership to accelerate innovation, from early development to market launch and beyond, while ensuring compliance and efficiency.
Who We Are
Our Services
End-to-end support across the full product development lifecycle:
Program & Project Leadership
Drug & Device Development Strategy
Commercial & Operations
Portfolio & Lifecycle Optimization
Quality, Compliance & Risk Management
Financial & Investor Support
Who We Serve
Biotech & Pharma Startups
Medical Device & Diagnostic Companies
Technology Companies
Academic & Professional Institutions
About the Founder
Ihab Rashad, MBA, PMP is the founder of NanoCoeur Consulting and a Biotech, Pharma, and MedTech Program and Operations Leader with over 15 years of experience advancing drug development, medical device, and in-vitro diagnostic (IVD) programs from early R&D through commercialization. Across oncology, orthopedics, diagnostics, and blood products, Ihab has built and led PMOs, secured FDA approvals including INDs, and guided cross-functional global teams through the full product lifecycle. His work has delivered over $50M in funding outcomes, cost savings, and operational efficiency gains for clients ranging from early-stage startups to established life sciences organizations. Ihab brings a practical, execution-focused approach to every engagement, translating complex regulatory, clinical, and operational challenges into clear strategy and results. He also integrates AI-powered workflows and automation where they reduce burden and accelerate delivery, helping lean teams move faster.